Transcranial magnetic stimulation combined with virtual reality improves quality of life in patients with Parkinson’s disease with depression

• by Ruiping Gu, Guizhen Zeng

• June 11, 2026

Identifying key predictors of post-stroke depression and cognitive impairment in acute stroke survivors

• by Zhiwen Yan, Huan Zhao, Jianjun Chen, Fang Liu, Lei Gong, Yingli Li, Jie Zhang, Mi Xiao, Jun Mu

• May 20, 2026

The association between systemic immune-inflammation index and post-stroke depression: a meta-analysis

• by Wendi Zhang, Geng Chang, Zhen Mu

• June 5, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min